Skip to main content

Onboard AI

Category: AI Safety

Onboard AI is a healthcare technology company focused on ensuring the safe and responsible deployment of ai models in medical settings. Their platform helps hospitals and healthcare institutions vet, validate, and manage ai models to ensure compliance, interoperability, and ethical use. Onboard AI was founded in 2023. The company is led by Troy Bannister. Based in New York, United States. Team size: 10-20. Total funding raised: $5M. Latest round: SAFE, $5.0M, 2024-11, led by NextView Ventures. Key investors include Chai, NextView Ventures, Meridian Street Capital, Cedars-Sinai.

Founded
2023
Headquarters
New York, United States
Team size
10-20
Total funding
$5M

Value proposition

Provides a secure framework for hospitals to adopt ai models by addressing regulatory compliance, data privacy, and algorithmic transparency—critical for high-stakes healthcare environments

Products and solutions

AI Model Vetting Platform, Compliance and Interoperability Tools, Healthcare AI Governance Framework, Customizable Validation Workflows

Unique value

Combines healthcare domain expertise (CEO Troy Bannister's 15+ years in healthcare) with ai safety frameworks, addressing the critical gap between ai innovation and real-world clinical deployment

Target customer

Hospitals, healthcare systems, and clinical institutions deploying ai models for diagnostics, treatment optimization, and operational efficiency

Industries served

Healthcare, Medical Diagnostics, Clinical Research, Health Insurance

Technology advantage

Leverages Bannister's prior experience with Particle Health (healthcare data interoperability) to create a platform that integrates seamlessly with existing healthcare IT infrastructure

How they differentiate

Onboard AI specializes in vetting healthcare AI models for safety, compliance, and regulatory standards, focusing exclusively on the healthcare sector. Competitors often operate in broader AI domains or lack healthcare-specific compliance expertise

Main competitors

HealthAI, Viz.ai, PathAI

Key partnerships

Partnership with Cedars-Sinai to scale responsible AI adoption, Potential collaborations with healthcare IT providers, Partnerships with ai model developers for pre-validation, Regulatory bodies for compliance certification

Notable customers

Cedars-Sinai, Leading hospitals across the U.S.

Major milestones

Launched core validation platform (2023), Secured $5M SAFE round (2024), Partnership with Cedars-Sinai (2024), Onboarded multiple healthcare institutions

Growth metrics

Partnerships with major U.S. hospital systems including Cedars-Sinai, adoption by multiple healthcare organizations, platform live at leading hospitals across the U.S.

Market positioning

Positioned as a niche leader in healthcare AI safety and validation, targeting hospitals, startups, and enterprises deploying AI in clinical settings. Emphasizes trust, compliance, and risk mitigation

Geographic focus

Primary focus on the United States, with potential expansion into Europe and other regions with maturing healthcare AI ecosystems

Patents and IP

No publicly listed patents as of 2025; strategy may focus on proprietary algorithms and trade secrets for competitive advantage, given the fast-evolving nature of ai safety frameworks

About Troy Bannister

15+ years in healthcare as EMT, M.S. in Biophysics from Georgetown University, founder of Particle Health (healthcare data interoperability platform) and Rota Health, with expertise in healthcare data interoperability and digital health innovation.

Official website: